AstraZeneca PLC (AZN)
NASDAQ: AZN · IEX Real-Time Price · USD
67.26
+0.69 (1.04%)
At close:
Mar 23, 2023, 4:00 PM
67.49
+0.23 (0.34%)
After-hours:
Mar 23, 2023, 4:09 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44,351 | 37,417 | 26,617 | 24,384 | 22,090 | 22,465 | 23,002 | 24,708 | 26,547 | 25,806 | |
| Revenue Growth (YoY) | 18.53% | 40.58% | 9.16% | 10.38% | -1.67% | -2.33% | -6.90% | -6.93% | 2.87% | -7.75% | |
| Cost of Revenue | 12,391 | 12,437 | 5,299 | 4,921 | 4,936 | 4,318 | 4,126 | 4,646 | 5,842 | 5,261 | |
| Gross Profit | 31,960 | 24,980 | 21,318 | 19,463 | 17,154 | 18,147 | 18,876 | 20,062 | 20,705 | 20,545 | |
| Selling, General & Admin | 18,955 | 15,680 | 11,693 | 11,682 | 10,031 | 10,233 | 9,413 | 11,112 | 13,000 | 12,206 | |
| Research & Development | 9,762 | 9,736 | 5,991 | 6,059 | 5,932 | 5,757 | 5,890 | 5,997 | 5,579 | 4,821 | |
| Other Operating Expenses | -514 | -1,492 | -1,528 | -1,202 | -2,196 | -1,520 | -1,329 | -1,161 | -11 | -194 | |
| Operating Expenses | 28,203 | 23,924 | 16,156 | 16,539 | 13,767 | 14,470 | 13,974 | 15,948 | 18,568 | 16,833 | |
| Operating Income | 3,757 | 1,056 | 5,162 | 2,924 | 3,387 | 3,677 | 4,902 | 4,114 | 2,137 | 3,712 | |
| Interest Expense / Income | 1,346 | 1,300 | 1,306 | 1,432 | 1,419 | 1,508 | 1,384 | 1,075 | 963 | 495 | |
| Other Expense / Income | -85 | 24 | -112 | -164 | -130 | -191 | -127 | -29 | -70 | -35 | |
| Pretax Income | 2,496 | -268 | 3,968 | 1,656 | 2,098 | 2,360 | 3,645 | 3,068 | 1,244 | 3,252 | |
| Income Tax | -792 | -380 | 772 | 321 | -57 | -641 | 146 | 243 | 11 | 696 | |
| Net Income | 3,288 | 112 | 3,196 | 1,335 | 2,155 | 3,001 | 3,499 | 2,825 | 1,233 | 2,556 | |
| Net Income Growth | 2835.71% | -96.50% | 139.40% | -38.05% | -28.19% | -14.23% | 23.86% | 129.12% | -51.76% | -59.04% | |
| Shares Outstanding (Basic) | 1,548 | 1,418 | 1,312 | 1,301 | 1,267 | 1,266 | 1,265 | 1,264 | 1,262 | 1,252 | |
| Shares Outstanding (Diluted) | 1,560 | 1,427 | 1,313 | 1,301 | 1,267 | 1,267 | 1,266 | 1,265 | 1,264 | 1,254 | |
| Shares Change | 9.32% | 8.68% | 0.92% | 2.68% | - | 0.08% | 0.08% | 0.08% | 0.80% | -0.79% | |
| EPS (Basic) | 1.06 | 0.04 | 1.22 | 0.52 | 0.85 | 1.19 | 1.39 | 1.11 | 0.49 | 1.02 | |
| EPS (Diluted) | 1.05 | 0.04 | 1.22 | 0.52 | 0.85 | 1.19 | 1.38 | 1.11 | 0.49 | 1.02 | |
| EPS Growth | 2537.50% | -96.72% | 136.89% | -39.41% | -28.27% | -14.13% | 23.77% | 127.55% | -51.96% | -58.70% | |
| Free Cash Flow Per Share | 3.05 | 1.93 | 1.86 | 0.78 | 0.63 | 0.92 | 1.10 | 0.81 | 2.46 | 2.69 | |
| Dividend Per Share | 1.450 | 1.400 | 1.400 | 1.400 | 1.400 | 1.400 | 1.400 | 2.350 | 2.800 | 2.800 | |
| Dividend Growth | 3.57% | - | - | - | - | - | -40.43% | -16.07% | - | -1.75% | |
| Gross Margin | 72.06% | 66.76% | 80.09% | 79.82% | 77.66% | 80.78% | 82.06% | 81.20% | 77.99% | 79.61% | |
| Operating Margin | 8.47% | 2.82% | 19.39% | 11.99% | 15.33% | 16.37% | 21.31% | 16.65% | 8.05% | 14.38% | |
| Profit Margin | 7.41% | 0.30% | 12.01% | 5.47% | 9.76% | 13.36% | 15.21% | 11.43% | 4.64% | 9.90% | |
| Free Cash Flow Margin | 21.30% | 14.62% | 18.39% | 8.31% | 7.18% | 10.39% | 12.09% | 8.27% | 23.37% | 26.07% | |
| Effective Tax Rate | -31.73% | - | 19.46% | 19.38% | -2.72% | -27.16% | 4.01% | 7.92% | 0.88% | 21.40% | |
| EBITDA | 9,322 | 7,562 | 8,423 | 6,850 | 7,270 | 6,904 | 7,386 | 6,995 | 5,489 | 8,330 | |
| EBITDA Margin | 21.02% | 20.21% | 31.65% | 28.09% | 32.91% | 30.73% | 32.11% | 28.31% | 20.68% | 32.28% | |
| Depreciation & Amortization | 5,480 | 6,530 | 3,149 | 3,762 | 3,753 | 3,036 | 2,357 | 2,852 | 3,282 | 4,583 | |
| EBIT | 3,842 | 1,032 | 5,274 | 3,088 | 3,517 | 3,868 | 5,029 | 4,143 | 2,207 | 3,747 | |
| EBIT Margin | 8.66% | 2.76% | 19.81% | 12.66% | 15.92% | 17.22% | 21.86% | 16.77% | 8.31% | 14.52% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).